Metformin, a promising oral antihyperglycemic for the treatment of noninsulin-dependent diabetes mellitus

Keyphrases

• Metformin 100%
• Non-insulin-dependent Diabetes Mellitus (NIDDM) 100%
• Oral Antihyperglycemic Agents 100%
• Hyperinsulinism 100%
• Low Blood Glucose 66%
• Insulin Resistance 33%
• Insulin 33%
• Hyperglycemia 33%
• Hypertension 33%
• Cardiovascular Risk 33%
• Hypertriglyceridemia 33%
• Therapeutic Potential 33%
• Serum Insulin 33%
• Diet Therapy 33%
• Patient Selection 33%
• Beneficial Effects 33%
• Medical Intervention 33%
• High-density Lipoprotein Cholesterol (HDL-C) 33%
• Insulin Concentration 33%
• Blood Glucose 33%
• Lipid Profile 33%
• Biguanides 33%
• Oral Hypoglycemic Agents 33%
• Antihyperglycemic 33%
• Diabetes Mellitus Treatment 33%
• Sulfonylurea 33%
• Cardiovascular Sequelae 33%

Medicine and Dentistry

• Maturity Onset Diabetes of the Young 100%
• Glycon 100%
• Hyperinsulinism 100%
• Blood Glucose 66%
• Cardiovascular System 33%
• Cardiovascular Risk 33%
• Insulin Resistance 33%
• Sequela 33%
• Hypertriglyceridemia 33%
• Diabetes Mellitus 33%
• Diet Therapy 33%
• Hyperglycemia 33%
• Medical Intervention 33%
• High Density Lipoprotein Cholesterol 33%
• Oral Antidiabetic Agent 33%
• Biguanide 33%
• Sulfonylurea 33%